跳至主要内容
临床试验/RBR-4yq8n9
RBR-4yq8n9已完成未知

Drug evaluation in third molar surgeries. Blind, randomized clinical trial in divided mouth

Instituto de Ciência e Tecnologia - Câmpus de São José dos Campos0 个研究点开始时间: 2020年3月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
15Y 至 40Y(—)

入选标准

  • Patients in need of extraction of third molars, regardless of gender; presence of teeth in opposite hemiarchs with similar positions; patients aged between 15 and 40 years; patients who voluntarily agree to participate in the research, being aware of the risks and benefits, and signing the Informed Consent Form (ICF).

排除标准

  • Patients with local or systemic changes that contraindicate the procedure; use of anti-inflammatory drugs in the last 15 days; presence of lower third molars in different position and classification of inclusion on both sides; erupted lower third molars; patients allergic to amoxicillin.

研究者

发起方
Instituto de Ciência e Tecnologia - Câmpus de São José dos Campos

相似试验

Evaluation of the use of medications in wisdom tooth... | 临床试验